Althea is an Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis and is listed publicly on the Australian Securities Exchange (ASX:AGH).
Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.
Althea currently operates within highly regulated medicinal cannabis markets including Australia and the United Kingdom, with plans to expand into emerging markets throughout Asia and Europe.
Althea is committed to ensuring patients are supplied with full spectrum medicinal cannabis products. The quality and consistency of Althea medicinal cannabis products are ensured by strict quality standards.
Althea supplies pharmaceutical grade medicinal cannabis products to help improve the lives of patients suffering from debilitating conditions.
Education and resources for patients and healthcare professionals. Althea is dedicated to supporting eligible patients and healthcare professionals who are seeking information and access to medicinal cannabis.
A free online service designed to simplify the process for accessing medicinal cannabis for patients, healthcare professionals and pharmacies. Through Concierge, healthcare professionals can access patient treatment plans with detailed information on dosing and titration specific to the Althea product prescribed. Each treatment plan also allows patients to record feedback at each stage of the titration process. It is important that patients receive full instructions on how to safely use and titrate their medicinal cannabis, so that they can get the best out of their treatment.